Global Intussusception Market Projected to Surpass $5.52 Billion by 2029 with 4.1% Annual Growth

What Are the Market Size and Growth Forecast for the Intussusception Market?
The intussusception market will grow from $4.45 billion in 2024 to $4.69 billion in 2025, at a CAGR of 5.3%. Growth factors include improved diagnostic capabilities, increased awareness and education, global healthcare infrastructure growth, and increased research and development investments.

The Intussusception market will reach $5.52 billion by 2029 at a CAGR of 4.1%, driven by pediatric vaccination, postoperative care, and telemedicine. Trends include diagnostic imaging advancements, minimally invasive treatments, and global epidemiological studies.

What Is Contributing to the Growth of the Intussusception Market?
The rising incidence of intestinal disorders is expected to drive the growth of the intussusception market. Intestinal disorders refer to conditions that affect the normal functioning of the intestines, which are responsible for nutrient absorption and waste elimination. The growing incidence of disorders like inflammatory bowel disease and gastrointestinal cancers can lead to earlier diagnoses, improved treatment options, and better support for intussusception patients. For example, in January 2023, the American Cancer Society reported a 3.18% increase in gastrointestinal cancers in the United States, reaching 348,840 cases in 2022. Therefore, the rising incidence of intestinal disorders is expected to drive the growth of the intussusception market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13466&type=smp

Which Key Market Leaders Are Driving Intussusception Industry Growth?
Major companies operating in the intussusception market report are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline PLC, Stryker Corporation, Boston Scientific Corporation, Biogen Inc., Olympus Corporation, GE HealthCare Technologies Inc., Steris PLC, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, Janssen Pharmaceuticals Inc., EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Basilea Pharmaceutica Ltd., Richard Wolf GmbH, Karl Storz SE And Co. KG, Eizoflex Co. Ltd., Arena Pharmaceuticals Inc.

Which Key Developments Are Influencing the Intussusception Market?
Key companies in the intestinal pseudo-obstruction treatment market are developing novel drug therapies, such as NHE3 inhibitor treatment, to provide reliable solutions for patients. NHE3 inhibitor therapy targets the Sodium-Proton-Exchanger subtype 3 (NHE3) in the gut, aiding in gastrointestinal motility. For example, in April 2022, Ardelyx Inc., a US-based biopharmaceutical company, introduced IBSRELA, an NHE3 inhibitor treatment for adults with irritable bowel syndrome with constipation (IBS-C). This medication works by blocking the NHE3 protein, helping to alleviate symptoms. Approval for IBSRELA was based on two Phase 3 trials involving over 1,200 IBS-C patients, demonstrating significant improvements in abdominal pain and bowel movements as early as Week 1, with sustained effects for up to 26 weeks in long-term studies.

What Are the Main Segments in the Intussusception Market?
The intussusception market covered in this report is segmented -

1) By Type: Idiopathic Intussusception, Secondary Intussusception
2) By Treatment: Enema Reduction, Surgery, Other Treatment
3) By Diagnosis: Barium Enema, Ultrasound, X-Ray, Computerized Tomography (CT)
4) By End-User: Hospitals, Clinics, Other End-User

Subsegments:
1) By Idiopathic Intussusception: Childhood Idiopathic Intussusception, Adult Idiopathic Intussusception
2) By Secondary Intussusception: Neoplastic Intussusception, Infectious Intussusception, Inflammatory Intussusception, Post-Surgical Intussusception

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/intussusception-global-market-report

Which Geographic Area Leads the Intussusception Market?
North America was the largest region in the intussusception market in 2024. The regions covered in the intussusception market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Intussusception Global Market Report?

- Market Size Analysis: Analyze the Intussusception Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Intussusception Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Intussusception Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Intussusception Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13466

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.